The effect of released new synthetic peptide from nanofibrous scaffold of peptide/Poly (Vinyl Alcohol)/Poly l-Lactic Acid on expression of Secretory aspartyl proteinases 4 to 6 genes of Candida albicans

Infect Genet Evol. 2019 Jun:70:36-41. doi: 10.1016/j.meegid.2019.02.015. Epub 2019 Feb 18.

Abstract

Secreted aspartyl proteinases (Saps), are gene products that have been shown to directly contribute to Candida albicans pathogenicity. Despite the clear difficulties of systemic C. albicans infections control, Antimicrobial peptides (AMPs) are regarded as one of the most promising alternatives in this regard. Recently, drug-loaded electrospun nanofibers have attracted a great deal of attention. In this study we have established the nanofibrous scaffold of new synthetic peptide/Poly (Vinyl Alcohol)/Poly l-Lactic Acid on expression of Secretory aspartyl proteinases 4 to 6 genes of C. albicans in comparison with free peptide. We designed new synthetic Antimicrobial peptide (AMPs) used bioinformatics tools to predict structure and stabilities. The electrospinning method was used to produce the polymeric nanofibers. Scanning Electron Microscopy (SEM) was used to measure the nanofibers diameters and morphology. To analyze the expression of SAP4, SAP5 and SAP6 genes, RNA was extracted from clinical isolates of C. albicans before and after treatment with subinhibitory concentrations of new synthetic peptide on nanofibrous scaffold of new synthetic peptide/PVA/PLLA and then the cDNA was synthesized and used for Real-time PCR assay. Scanning electron microscopy (SEM) images showed that the morphology, the diameter, are affected from peptide. Reletive quantitative Real-time PCR results revealed that the mRNA levels of SAP4, SAP5 and SAP6 genes significantly decreased after treatment with nanofibrous scaffold of new synthetic peptide/PVA/PLLA (P < .05). Electrospun nanofibrous of new Synthetic Peptide/PVA/PLLA is effective in downregulating of expression SAP4, SAP5 and SAP6 genes of C. albicans strains.

Keywords: Antifungal; Candida albicans; Gene expression; Nanofibers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / chemical synthesis*
  • Antifungal Agents / therapeutic use
  • Aspartic Acid Proteases / biosynthesis*
  • Aspartic Acid Proteases / genetics
  • Biocompatible Materials / therapeutic use
  • Candida albicans / genetics
  • Candida albicans / pathogenicity*
  • Chemistry Techniques, Synthetic
  • Fungal Proteins / biosynthesis
  • Fungal Proteins / genetics
  • Nanofibers* / chemistry
  • Nanofibers* / therapeutic use
  • Peptides / chemical synthesis*
  • Peptides / therapeutic use
  • Polylactic Acid-Polyglycolic Acid Copolymer / therapeutic use

Substances

  • Antifungal Agents
  • Biocompatible Materials
  • Fungal Proteins
  • Peptides
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Aspartic Acid Proteases